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REVIEW
Getting the Best Outcomes from
Epilepsy Surgery
Vejay N. Vakharia, MRCS ,1 John S. Duncan, FRCP,1 Juri-Alexander Witt, PhD,2
Christian E. Elger, FRCP,2 Richard Staba, PhD,3 and Jerome Engel Jr, PhD3
Neurosurgery is an underutilized treatment that can potentially cure drug-refractory epilepsy. Careful, multidisciplin-
ary presurgical evaluation is vital for selecting patients and to ensure optimal outcomes. Advances in neuroimaging
have improved diagnosis and guided surgical intervention. Invasive electroencephalography allows the evaluation of
complex patients who would otherwise not be candidates for neurosurgery. We review the current state of the
assessment and selection of patients and consider established and novel surgical procedures and associated out-
come data. We aim to dispel myths that may inhibit physicians from referring and patients from considering neuro-
surgical intervention for drug-refractory focal epilepsies.
ANN NEUROL 2018;83:676–690
Surgery is effective for many patients with drug-resistant epilepsy (DRE), but it is underutilized.1
After a randomized trial of surgery for temporal lobe epi-
lepsy (TLE) 2 reported 64% seizure freedom, surgery was
recommended as the treatment of choice for drug-
resistant TLE.3 A subsequent trial of surgery for drug-
resistant TLE of <2 years reported 85% seizure freedom,
and improved quality of life and socialization.4
In the USA, <1% of patients with continuing seiz-
ures are referred to epilepsy centers.1 The delay from
onset of epilepsy to surgery averages >20 years, resulting
in impaired social and educational development.5 Early
surgery provides the best opportunity for seizure remis-
sion, minimizing adverse social and psychological conse-
quences and premature death.
Reasons for Underutilization of Epilepsy
Surgery
Common reasons for rejecting surgery include fear of com-
plications, expense, and reservations about benefits. In
actuality, morbidity and mortality from recurrent seizures
are much greater than from surgical treatment,6 and the
cost is considerably less than that of a lifetime of disabil-
ity.7 The delay to surgical referral has not changed in
recent years,8,9 and referrals to epilepsy surgery centers
have decreased.10 This may be due to a decrease in mesial
TLE, and because some patients are having surgery at low-
volume hospitals, where outcomes are less good. Of
patients who undergo phase 1 noninvasive evaluation
(magnetic resonance imaging [MRI], language functional
MRI [fMRI], neuropsychology, neuropsychiatry, scalp
video-electroencephalography [EEG]) after an outpatient
screening visit at an epilepsy surgery center, it may be
expected that half will not proceed further, 25 to 40% may
be recommended for resection without further investiga-
tion, and 10 to 25% will require intracranial EEG.
A likely reason for underreferral is misconceptions
held by nonspecialist physicians (Table 1). It has been
suggested, therefore, that surgery per se should not be
emphasized as a reason for referral, but all patients with
refractory epilepsy merit review at an epilepsy center,
where there are a range of treatment options, including
consideration of surgery.1
Patient Selection
Mesial TLE is the prototypical surgically remediable epi-
lepsy syndrome. Others include discrete neocortical
lesions such as focal cortical dysplasias and diffuse lesions
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limited to one hemisphere. Excellent outcomes can also
be achieved in patients with multiple lesions, for exam-
ple, tuberous sclerosis when one tuber is the source of
seizures. The best prognostic factor for a good outcome
is a discrete structural lesion on MRI, in an area that can
be safely removed, which conforms to the location of
ictal EEG changes and is consistent with seizure semiol-
ogy. Conversely, the occurrence of generalized tonic–
clonic seizures, a normal MRI, extratemporal onset, psy-
chiatric comorbidity, and learning disability reduce the
chances.11
Measuring Outcome
The success of surgery for DRE is assessed by postopera-
tive seizures and effects on health-related quality of life
(HRQOL). There are 2 seizure outcome scales. In the
Engel scale, the seizure-free category can be divided into
continued auras and aura-free.12 The International
League against Epilepsy (ILAE) scale considers seizure
freedom, continued auras, and postoperative seizures in
terms of improvement or lack thereof from the preopera-
tive seizure status with a 6-point scale.13 These scales are
not so useful for patients with severe epilepsies when the
intervention is palliative and it can be ascertained what
the patients or their caregivers expect to gain from sur-
gery. A “contract” is then made and success or failure
determined by whether the contract is fulfilled.14 Seizure
outcome needs to be considered in the long term, with
the recognition that there is an attrition rate of seizure
freedom over the following 10 to 20 years, and some
may remit after some years.11
Evaluation of epilepsy surgery usefully includes
HRQOL measures that determine effects on school and
work performance, domiciliary arrangements, driving,
interpersonal relationships, memory, and other cognitive
functions.
Presurgical Investigations
Evolving Role of Brain Imaging
Presurgical evaluation aims to localize the epileptogenic
zone (EZ) that must be removed to give seizure freedom
through the integration of seizure semiology, EEG, neuro-
psychological evaluation, and multimodal imaging.
Patients with an identified epileptogenic lesion have 2.5
times higher odds of seizure freedom following surgery
than those without.15 Advances in MRI, nuclear medicine,
and source localization techniques can help to improve
delineation of the EZ. Surgically remediable lesions
include developmental abnormalities, infections, neoplasia,
stroke, trauma, and vascular malformations.16 Optimized
imaging acquisition and interpretation increase the detec-
tion of epileptogenic lesions (Table 2).17
MRI
Epilepsy imaging protocols have been suggested by the
ILAE,18 and optimal MRI protocols have been defined.19
The mainstay is high-quality structural 3T MRI (Fig 1).
TABLE 1. Common Misconceptions about Epilepsy Surgery
Misconception Fact
All drugs need to be tried. The chance of seizure remission is <10% after 2 drugs have
failed.
Bilateral EEG spikes are a contraindication to surgery. Patients with unilateral seizure onset commonly have bilateral
interictal spikes.
Normal MRI is a contraindication to surgery. Other techniques often detect a single epileptogenic zone in
patients with normal MRIs.
Multiple or diffuse lesions on MRI are a contraindication
to surgery.
The epileptogenic zone may involve one or part of a lesion.
Surgery is not possible if eloquent cortex is involved. The risk–benefit ratio can be individually evaluated.
Surgery will make memory worse if there is an existing
memory deficit.
Poor memory usually will not get worse and may improve.
Chronic psychosis is a contraindication to surgery. Patients may benefit if seizures are eliminated.
IQ< 70 is a contraindication to surgery. Individuals with IQ< 70 may benefit from remission
or reduction in seizures.
EEG5 electroencephalography; IQ5 intelligence quotient; MRI5magnetic resonance imaging.
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This provides higher identification of lesions than 1.5T
scans.20
Volumetric T1-weighted gradient-recalled echo
(GRE) images provide sharp gray/white matter distinc-
tion for detection of subtle malformations of cortical
development. One-millimeter isotropic voxels allow refor-
matting in additional planes and segmentation of the
hippocampus for volumetric measurements that may
identify subtle atrophy and determine the structural
integrity of the contralateral hippocampus.21 Gadolinium
enhancement is recommended when tumors, infection,
or neurocutaneous syndromes are suspected.22
High-resolution T2-weighted coronal images
acquired in a plane perpendicular to the long axis of the
hippocampus give optimal resolution. T2* sequences
such as GRE or susceptibility-weighted images improve
the detection of calcified or hemorrhagic lesions.
Hippocampal sclerosis is the most commonly identified
pathology in surgical series and is characterized by hippocam-
pal atrophy and increased T2 signal intensity. Visual inspec-
tion can miss subtle, focal, or bilateral hippocampal sclerosis.
T2 relaxometry quantifies the T2 relaxation time along the
length of the hippocampus. Quantification increases detec-
tion of hippocampal sclerosis.23 Three-dimensional (3D) T2-
weighted fluid-attenuated inversion recovery sequences may
detect focal cortical dysplasias at the bottom of a sulcus, with
blurring of the gray–white boundary and dyslamination
extending into the white matter. Postacquisition processing of
MRI may increase detection of subtle abnormalities, but
reduced specificity is the price of increased sensitivity.24–26
If a lesion is detected that is concordant with clini-
cal semiology, with interictal and ictal video-EEG, and
with satisfactory neuropsychological and neuropsychiatric
assessments, no further investigation may be required
before definitive surgery. If the planned resection margins
are close to eloquent cortex, functional mapping such as
language and motor fMRI and transcranial magnetic
stimulation may help to delineate resection boundaries.27
The commonly used fMRI language paradigms ver-
bal fluency and verb generation lateralize, rather than
precisely localize, language functions. The sensitivity and
specificity of fMRI for language lateralization is between
80 and 90% and has replaced the intracarotid sodium
amobarbital procedure in most cases.27
Tractography is derived from diffusion-weighted
MRI sequences and can localize major white matter
tracts such as the corticospinal tract and optic radiation.
Tractographic and dissection studies have shown consid-
erable variability in the anterior extent of Meyer’s loop,
ranging from 20 to 50mm from the temporal pole.28
TABLE 2. Imaging Sequences Commonly Employed for Presurgical Evaluation
MRI 3D volumetric T1-weighted imaging (1mm isotropic voxels) in AC-PC angulation
T2-weighted axial and coronal images (<3mm slice thickness) angulated perpendicular
to hippocampal axis
3D volumetric FLAIR (1mm isotropic voxels) or axial and coronal images (<3mm
slice thickness) angulated perpendicular to hippocampal axis
T2* gradient echo or susceptibility-weighted axial imaging angulated perpendicular to
hippocampal axis
Confirmation of epileptogenic zone 18F-FDG PET
Ictal interictal subtraction SPECT
MEG
Electrical source imaging
EEG-fMRI
Eloquent function
mapping
Language and motor functional MRI
Tractography
Transcranial magnetic stimulation
aF-FDG5 18F-fluorodeoxyglucose; 3D5 3-dimensional; AC-PC5 anterior and posterior commissure; EEG5 electroencephalography;
FLAIR5 fluid-attenuated inversion recovery; fMRI5 functional MRI; MEG5magnetoencephalography; MRI5magnetic resonance imaging;
PET5 positron emission tomography; SPECT5single photon emission computer tomography.
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FIGURE 1: Magnetic resonance imaging of common pathologies underlying drug-resistant focal epilepsy that are amenable to surgi-
cal treatment. (A) Coronal fluid-attenuated inversion recovery (FLAIR) image showing increased T2 signal in the left hippocampus
associated with volume loss and compensatory dilatation of the left temporal horn consistent with left hippocampal sclerosis. (B)
Nonenhanced axial T1-weighted image of a patient with a lesion in the left temporal lobe that has a “popcorn” appearance due to a
hemosiderin ring and mixed intensity blood products consistent with a cavernoma. (C) Nonenhanced coronal T1-weighted image of
a patient with multiple bilateral well-demarcated periventricular lesions that have imaging characteristics matching gray matter con-
sistent with nodular periventricular heterotopia. This is associated with polymicrogyrialike overlying cortex. Note is also made of a
posterior fossa arachnoid cyst and ventricular asymmetry. (D) Coronal FLAIR image of a patient with a sharply demarcated cortically
based “pseudocystic” lesion in the right supramarginal gyrus that returns a hyperintense signal, consistent with a dysembryoplastic
neuroepithelial tumor. There is associated overlying calvarial remodeling. (E) Sagittal T1-weighted image through the left temporal
lobe revealing herniation of the temporal pole through the floor of the middle cranial fossa consistent with a meningoencephalocele.
(F) Coronal FLAIR image with increased signal and expansion of the left amygdala. Contrast-enhanced imaging did not reveal any
enhancement, consistent with a diffusely infiltrating low-grade glioma. (G) Axial FLAIR image revealing increased signal in the right
occipital lobe with blurring of the cortical–subcortical margin consistent with type 2B focal cortical dysplasia.
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Anterior temporal lobe resections may cause visual field
deficits that preclude up to 50% of patients from driving
even if they are seizure-free.29 Presenting the tracto-
graphic representation of the optic radiation into the sur-
gical microscope eyepiece during temporal lobe resection
prevented visual field defects.30
Novel MRI contrasts may identify covert lesions.
Diffusion kurtosis imaging provides improved gray–white
matter contrast and may act as a biomarker for severity
and disease subtypes.31
Nuclear Medicine
If MRI does not identify a lesion that is concordant with
clinical and EEG data, functional imaging with positron
emission tomography (PET) or single photon emission
computer tomography (SPECT) may be useful.
PET imaging is generally performed interictally,
due to the short unpredictable nature of spontaneous
seizures, identifying hypometabolism as a marker of cor-
tical dysfunction. PET MRI provides better anatomical
and functional information than PET computed tomog-
raphy.32 Interictal PET has a sensitivity of up to 90% in
temporal and 50% in extratemporal lobe epilepsy.33 The
region of hypometabolism detected by 18F-fluorodeoxy-
glucose (18F-FDG) PET is generally larger than the EZ
and cannot be used to outline a surgical resection plan.
18F-FDG PET may aid hemispheric lateralization and
general lobar localization in cases with discordant scalp
EEG and/or normal MRI. The overall positive predictive
value of a good outcome following 18F-FDG PET in
TLE was 77.5% when MRI, EEG, or both were noncon-
cordant. Specific PET ligands for c-aminobutyric acid
type A, N-methyl-D-aspartate, opioid, and serotonin
receptors have research applications but are not in wide-
spread use.34
SPECT imaging utilizes technetium-99m–labeled
ligands to measure regional cerebral blood flow (rCBF).
The tracer can be administered at the time of seizure
onset and will be distributed in the brain to reflect rCBF
at the time of injection. Tracer administration as early
after seizure onset as possible is crucial to identify hyper-
perfusion associated with the seizure onset zone (SOZ).
Delayed administration visualizes areas that show hyper-
perfusion due to seizure propagation. Ictal SPECT had a
70% sensitivity compared to 78% with interictal 18F-
FDG PET.35 When ictal and interictal SPECT are nor-
malized and subtracted, the sensitivity of SPECT has
reached 87%.36
Other Functional Imaging Methods
Simultaneous scalp EEG-fMRI can show hemodynamic
changes associated with interictal epileptic discharges
with 30 to 40% sensitivity37 and may assist planning
intracranial implantations,38 with widespread abnormali-
ties associated with poor outcome from resection.39 Ictal
EEG-fMRI often shows widespread hemodynamic
changes before the onset of the seizure on scalp EEG,40
highlighting the low sensitivity of scalp EEG. The cur-
rent clinical place of scalp EEG-fMRI is visualization of
ictal and interictal networks that may help design intra-
cranial EEG strategies and indicating whether there is
likely to be a poor outcome, which may justify stopping
further investigation.
Magnetoencephalography (MEG) measures the
magnetic field generated by synchronized postsynaptic
currents in cortical pyramidal cell dendrites. In magnetic
source imaging, current dipole maps of interictal spikes
are overlaid onto an MRI scan. The spatial and temporal
resolution of MEG is superior to scalp EEG but is lim-
ited to dipoles on the cortical surface and less sensitive to
deeper sources. In patients in whom the MEG signal was
concordant with the resection, long-term seizure outcome
was Engel I in 85%, compared to 37% when the MEG
signal was not concordant.41 Thus, MEG has a limited
role in helping to define the EZ.
In clinical practice, EEG-fMRI, MEG, and electri-
cal source imaging (ESI) map interictal epileptic dis-
charges, with a small chance of recording seizures; this
chance is greater with ESI, because prolonged recordings
are possible. Patients who may benefit from these investi-
gations are those who require intracranial EEG to define
the EZ. These data may help generate a hypothesis to
test with intracranial EEG and to identify patients with
widespread abnormalities, who should not proceed.
3D Visualization
The 3D visualization of multimodal imaging demon-
strates the spatial relationships of normal and abnormal
structures and function in the brain. This is beneficial
for planning intracranial EEG placements and resection.
Computer-assisted planning of electrode insertion and
resection planning promise to simplify the epilepsy sur-
gery pathway (Fig 2).42,43
Place and Process of Intracranial EEG
Intracranial EEG recordings are performed to: (1) local-
ize the site of ictal onset when the hypotheses for loca-
tion of the EZ are reasonably limited, (2) define the
extent of the EZ when a tailored resection is required,
and (3) map essential cortical functions adjacent to con-
templated areas of resection.
Intracranial recordings include intraoperative elec-
trocorticography, and chronic extraoperative recording
using subdural or intraparenchymal depth electrodes.
ANNALS of Neurology
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In 1993, most centers agreed that intraoperative
electrocorticography, or chronic subdural grid or strip
recordings, were appropriate for a suspected EZ on the
cortical convexity, whereas depth electrodes were more
appropriate for a suspected EZ in deeper structures.44
Subdural grids or stereotactically placed EEG (SEEG)
recordings were necessary for functional mapping and
determination of the extent of the EZ to guide tailored
resection. The consensus was that both methods are use-
ful for neocortical EZ and both have limitations, the
choice being individualized for each patient.
There are no definitive criteria for determining the
EZ boundaries. The location of interictal spikes may
help but is often unreliable. The location of the ictal
FIGURE 2: (A) Three-dimensional cortical model. (B) Vascular segmentation from digital subtraction angiogram following left
internal carotid and vertebral injections. (C) Vascular segmentation with automated parcellation of anatomical regions of interest
(ROIs), including supplementary motor cortex, anterior insula, and hippocampus. (D) Automated electrode trajectory placement
targeting predefined anatomical ROIs. Not all of the implemented electrode trajectories or target ROIs are shown in this image.
(E) Postimplantation reconstruction of a different patient to that shown in A–D. Bolt and electrode contact points are segmented
from postimplantation computed tomography and overlaid on cortical model. Electrodes with contacts implicated at seizure
onset are shown in red, whereas those not involved at seizure onset are shown in white. Planned resection volume to include elec-
trodes at seizure onset is shown in green. For clarity, the bolts are displayed, not the individual electrode contact points.
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onset is important but does not determine the extent of
the EZ. There is a need for biomarkers that delineate the
EZ. Pathological high-frequency oscillations (pHFOs)
may serve this purpose.
There is a strong association between occurrence of
pHFOs and epileptogenic tissue.45 Although invasive
EEG is currently the gold standard for recording pHFOs,
new MEG methods could help detection.46
Poor seizure outcome was associated with high
“nonharmonicity” on the postresection electrocortico-
gram, which implies that residual tissue can generate epi-
leptiform activity.47 Good seizure outcome has been
predicted by a combination of low interictal EEG syn-
chrony outside the seizure onset zone (SOZ) and low
delta power (0–4Hz) inside the SOZ.48 Good seizure
outcome was predicted by removal of highly epilepto-
genic areas derived from mathematical models of interic-
tal EEG functional connectivity.49
Accuracy and Method of SEEG
The overall morbidity rate from SEEG has been reported
as 1.3% per patient, equating to a risk of 1 of 287 electro-
des. Hemorrhage occurred in 1% of patients.50 Methods
used to detect intracranial vasculature are varied. Some
units use contrast enhanced magnetic resonance (MR)
venography and angiography, whereas others perform digi-
tal subtraction catheter angiography (DSCA). DSCA is the
gold standard but is invasive and may require a general
anaesthetic.51 Proponents of MR venography do not con-
sider the additional vasculature visualized with DSCA to
be clinically relevant and have not reported increased hem-
orrhage rates.52
Planning SEEG electrode placement is time-
consuming and requires a multidisciplinary approach to
ensure adequate sampling of regions consistent with the
electrophysiological hypothesis. Generally, SEEG electro-
des are planned to enter the brain on the crown of a
gyrus, maximize distance from cerebral vasculature, not
transgress sulcal pial boundaries, not come within 10mm
of other implanted electrodes, cross the skull orthogo-
nally, have the shortest feasible intracranial length, and
maximize gray matter contact.
Cardinale et al suggested a 3mm safety margin from
cerebral vasculature.53 Computer-assisted planning algo-
rithms increase safety and reduce the time taken (see Fig
2).42,54,55 Implantation methods for SEEG include frame-
based, frameless, and robotic systems. Bone-anchored fidu-
cials are more accurate than scalp fiducials or surface trac-
ing registration methods. Frameless techniques are quicker
than frame-based systems, especially when 8 to 14 SEEG
electrodes are inserted, at the relative cost of accuracy.
Robotic systems allow highly accurate electrode placement
with shorter implantation times than frame-based or
frameless systems. Accuracy data have been published for
Neuromate, ROSA, and iSYS1. A meta-analysis of accura-
cies of implantation methods revealed significant heteroge-
neity between studies, mainly due to use of different
accuracy measures.56 Robotic guidance achieved a median
0.78mm entry point and 1.77mm target point error, com-
pared to a median 1.43mm entry point and 2.69mm target
point error with manual Talairach frame placement.53
Scope of Surgical Treatment
Types of Surgical Procedures
Some resections may be standardized when the EZ is
within recognized boundaries, for example anterior tempo-
ral resections for mesial TLE, and hemispherectomies for
diffuse lesions. Neocortical resections are usually tailored
based on electrophysiological and imaging data con-
strained by proximity to eloquent cortex, such as language
or motor areas. Palliative procedures include disconnec-
tion, such as corpus callosotomy, for disabling drop
attacks. Palliative neuromodulation includes vagus nerve
stimulation, deep brain stimulation,57 and responsive neu-
rostimulation and are considered when there is not a sin-
gle, removable EZ.58 These may reduce seizure frequency
and severity, but very rarely bring seizure freedom.59
TEMPORAL LOBE RESECTION. The most common
anterior temporal resection procedure includes resection of
up to 4.5cm neocortex, measured from the temporal pole
to minimize visual and speech deficits, and an en bloc
resection of the amygdala, hippocampus, parahippocam-
pus, uncus, and fusiform gyrus via the temporal horn.60 In
a meta-analysis, anterior temporal lobectomy had an
8% greater seizure freedom rate than transcortical selective
amygdalohippocampectomy.61 Amygdalohippocampec-
tomy was associated with better postoperative memory
than temporal pole and hippocampal resection.62
FRONTAL LOBE RESECTION. Frontal lobe resections
account for up to 30% of cases and carry a 1-year seizure
remission rate of approximately 45% (range5 21–61%)
and less durable long-term outcomes.63 The EZ fre-
quently extends beyond MRI-defined lesions, and the
resection may need to be tailored according to invasive
EEG findings.64 The best postoperative outcome is asso-
ciated with type 2B focal cortical dysplasia, a focal sei-
zure onset, and total resection of the EZ.63,64
INSULA RESECTION. Seizure remission rates of 60 to
70%65 and 84% in a series of insular tumors66 have been
reported. Insula resections, without a well-defined lesion
on MRI, require a careful analysis of the risk–benefit ratio,
especially in the language-dominant hemisphere.
ANNALS of Neurology
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PARIETAL LOBE RESECTION. Parietal seizures may
have few localizing semiological features but can present
with somatosensory disturbances, vertigo, psychic symp-
toms, and language dysfunction.67 Propagation to the
frontal lobes results in hyperkinetic seizures, and spread
to the temporal lobe causes automatisms. Engel I out-
comes range between 45 and 78%, with the best being
associated with a focal MRI lesion.68
OCCIPITAL LOBE RESECTION. Scalp EEG demon-
strated occipital interictal spikes in only 17%.69 Resection
had an average Engel I outcome in 65% (range5 20–
100%).70 A discrete MRI lesion and age< 18 years were
predictive of successful surgical outcome. Occipital lobe
epilepsy surgery carries significant risk of postoperative
visual dysfunction.
FUNCTIONAL HEMISPHERECTOMY. When the EZ is
extensive in one hemisphere, hemispherotomy, or functional
hemispherectomy, may be considered. Generally, this is
restricted to individuals who have a hemiparesis with loss of
meaningful hand function.71 Seizure freedom occurred in
73%.72 Most patients who are walking prior to surgery
remain so afterward. There is loss of any fine motor skills in
the contralateral upper and lower limbs, whereas cognitive
outcomes are usually stable, with language functions having
developed in the contralateral hemisphere.72
CORPUS CALLOSOTOMY. Corpus callosotomy is a
palliative procedure for patients with generalized epilepsy
or diffuse bilateral or unilateral origin with rapid propa-
gation. Corpus callosotomy can be either anterior, poste-
rior, or total.73 Anterior callosotomy may be performed
first and converted to a total callosotomy if disabling
seizures continue. A posterior callosotomy spares inter-
frontal connections.74 Meta-analyses have shown a 59%
seizure reduction after anterior compared to 88% after
total corpus collosotomy.73
Novel Techniques
STEREOTACTIC RADIOSURGERY. Seizure-free out-
comes range from 0 to 86%, with a mean Engel I out-
come of 51%.75 Headache and cerebral edema are
common, frequently there is a transient increase in focal
seizures in the months following treatment, and there is
the possibility of radionecrosis.76 The ROSE (Radiosur-
gery or Open Surgery for Epilepsy) trial compared
gamma knife and surgery for mesial temporal lobe epi-
lepsy.77 The trial stopped early because of poor recruit-
ment, and results are awaited. Further uses of stereotactic
radiosurgery include corpus callosotomy and treatment of
hypothalamic hamartomas.78
LASER-INDUCED THERMAL THERAPY. MR-guided
laser-induced thermal therapy (MgLiTT) can produce a 5-
to 20mm-diameter focal ablation zone. Heating is moni-
tored using real-time MR thermography, allowing precise
control of the ablation zone. Two systems are in use, Visu-
alase (Medtronic, Plymouth, Minnesota) and NeuroBlate
(Monteris Medical, Minneapolis, MN). The Visualase sys-
tem has been used for hypothalamic hamartoma (HH),
focal cortical dysplasia,79,80 periventricular heterotopia,81
and mesial temporal lobe epilepsy (MTLE).82 Sixty-five
percent of MTLE had an Engel I outcome at 1-year fol-
low-up.83 As with SEEG electrodes, laser trajectories
should avoid cerebral vasculature, pial sulcal boundaries,
and the lateral ventricle, and maximize ablation of the hip-
pocampus and amygdala. Computer-generated trajectories
improve ablation volume and calculated trajectory risk
compared to when manually planned (Fig 3).84,85 In a
nonrandomized comparison, MgLiTT gave similar out-
comes to conventional surgery.86 MgLiTT may result in
less adverse cognitive effects, is repeatable, does not pre-
clude subsequent surgery, and may represent a minimally
invasive first-line treatment for MTLE. Laser ablation of
HH resulted in 86% seizure freedom at a mean 9-month
follow-up and no permanent complications.87
MR-GUIDED ULTRASOUND. MR-guided focused ultra-
sound (MRgFUS) ablation is a minimally invasive method
of creating focal lesions.88 The lesion extent can be moni-
tored using MR thermography. The development of
1,000-array element transducers, active scalp cooling, and
improved focusing has produced a resurgence in interest in
transcranial MRgFUS for treating brain tumors and epi-
lepsy and performing functional procedures.
Neurological and Surgical Complications of
Epilepsy Surgery
Neurological complications of epilepsy surgery depend
on the extent and location of the surgical resection and
preexisting functional deficits and are governed by hemi-
spheric language dominance, vascular injury, and proxim-
ity to critical white matter tracts and eloquent cortex.
In a Cochrane review, the reported overall compli-
cation rate was 7.3%.89 Few studies report pre- and post-
operative neuropsychological assessment of cognition,
language, memory, social function, visual fields, and psy-
chiatric sequelae. Reported complication rates were
higher in patients older than 50 years and range from 6
to 25%.90 A review of almost 1,000 patients at a single
institution found the overall complication rate was
17%,91 with unanticipated long-term new neurologic
deficits in 3%. The most common complication was a
permanent visual field deficit, sufficient to preclude driv-
ing, in 9.4% following temporal lobe resection. The
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incidence of infection requiring bone flap removal was
2.6%. The risk of infection was 4-fold higher in those
having subdural EEG grid placement prior to resection.
Neuropsychological Evaluation and
Epilepsy Surgery
Cognitive Deficits in Epilepsy
Neuropsychological impairments in epilepsy are the result
of the underlying pathology, seizures, interictal epileptic
discharges, antiseizure drugs, and psychiatric comorbid-
ities.92 The impact of these factors depends on their onset
in relation to brain maturation, cognitive development,
and the brain’s ability to compensate for adverse impacts.
Compensatory mechanisms can maintain cognitive func-
tions that would have otherwise been compromised.
Neuropsychological Tests—Why, How,
Sensitivity, and Confounders
Neuropsychological evaluation is an essential component
of presurgical evaluation, providing valuable information
on lateralized and localized brain dysfunctions.93
Compensatory mechanisms can result in
“discordant” findings. For example, an early onset
lesional epilepsy may cause transfer of verbal functions to
the originally nondominant hemisphere, thereby sup-
pressing nonverbal functions.92
fMRI and the intracarotid amobarbital procedure92
can lateralize language and memory functions. The latter
is now reserved for rare circumstances, when structural
and fMRI and neuropsychological data do not give clar-
ity on the capacity of the contralateral hemisphere.
FIGURE 3: Axial, sagittal, coronal, and 3-dimensional reconstruction of planned laser ablation trajectory (red) with outline of
hippocampus (yellow), amygdala (cyan), and modeled ablation cavity (black). Other structures, such as the entorhinal cortex
and parahippocampal gyrus, have been excluded for clarity. The entry point of the trajectory is centered over the crown of a
gyrus, parallel to the superficial sulci. The ideal trajectory should maximize distance from vasculature, avoid crossing sulci or
the lateral ventricle. In this example, the entry point is within the inferior occipital gyrus and the target point is on the anterior
border of the amygdala. The Visualase (Medtronic) system is capable of performing an ablation diameter of between 5 and
20mm. The modeled ablation cavity shown above is based on a conservative estimate of 15mm.
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Corticographic mapping of language functions becomes
relevant when eloquent cortex is at risk.
The preoperative neuropsychological profile is
important when advising the patient about the cognitive
risks of the proposed surgery, and for estimating the
functional integrity of the structures to be resected and
the reserve capacities of the remaining brain.92
Neuropsychological assessment depends on the use
of measures that are sensitive to detect lateralized and
localized brain dysfunctions associated with epilepsy and
its underlying pathology. Given the high prevalence of
TLE, the validity of test measures has mostly been dem-
onstrated for left (verbal learning and memory, naming)
and less consistently for right (nonverbal/visual–spatial
learning and memory) temporal lobe functions.92 Pre-
frontal deficits (attention, executive functions, working
memory, and motor coordination) can be assessed,
although lateralization is challenging.92 An evidence-
based assessment of parietal and occipital epilepsies has
not been established, because experience with these epi-
lepsies is low.
Tests must be suitable for longitudinal reassessments
(sufficient retest reliability, parallel versions, and test–
retest norms). Surgical reference centers are currently
attempting to standardize assessments and provide
evidence-based recommendations for test selection.94
It is essential to consider the adverse cognitive
effects of medication93 and recent seizures. Furthermore,
psychiatric comorbidities may adversely affect test perfor-
mance,95 and these should be assessed by screening
measures.96
Determinants of Postoperative Outcome
Preserving cognition is a high priority. Inevitably, surgical
procedures carry a risk of cognitive deterioration. How-
ever, seizure control and reducing medication can lead to
cognitive improvement. The determinants of neuropsy-
chological outcome after epilepsy surgery are summarized
in Table 3.
Collateral damage and complications can have det-
rimental effects on cognition.97 Thus, more selective pro-
cedures (such as stereotactic thermocoagulation) are
valued from a neuropsychological perspective.
An important determinant of neuropsychological
outcome is the functional integrity of the resected struc-
tures.98 Resecting dysfunctional tissue is associated with a
TABLE 3. Determinants of Neuropsychological Outcome after Surgical Treatment of Epilepsy
Type and quality of surgery
Extent, side, and site of surgery
Degree of actual selectivity in terms of sparing functional tissues beyond the epileptogenic lesion
Collateral damage
Complications
Functional integrity of resected (and surgically affected) tissues
As estimated by the degree of pathology and the respective presurgical neuropsychological performance
Individual reserve capacities
Functional integrity of the remnant brain or homologue contralateral structures
Degree of functional plasticity
Age at surgery
Gender
Postsurgical control of epileptic activity
Epileptic seizures
Interictal epileptic discharges
Changes in antiepileptic treatment
Quantitative and qualitative changes of the drug regimen
Implantation of intracranial depth electrodes within subsequently nonresected tissues
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low risk, whereas resecting functional tissues carries a
high risk of cognitive deterioration. The functional integ-
rity can be estimated by the neuropsychological deficits
associated with the resection site, combined with imaging
markers of its structural integrity.99 fMRI for episodic
memory is emerging as a predictor of verbal memory
decline after anterior temporal lobe resection,100 and the
risk of word-finding difficulty after dominant temporal
lobe resection can be estimated with fMRI, but with less
specificity.101 In children, verbal memory improved after
right temporal lobe resection and visual memory
improved after left temporal lobe resection, suggesting
functional release of the contralateral side.102 After left
temporal lobe resection, verbal memory is better pre-
served with smaller medial temporal resections,102 and
the posterior hippocampus has a key role in preserving
memory.103
Further determinants of neuropsychological out-
come include the reserve capacity of the remnant brain,
the degree of age-dependent functional plasticity, postsur-
gical seizures, interictal epileptic discharges, and changes
of antiseizure medication.104 Additionally, depth electro-
des in subsequently nonresected tissues can negatively
affect cognitive outcome.105
Factors increasing risk of an unfavorable cognitive
outcome are: (1) an unimpaired neuropsychological pro-
file; (2) no MRI lesion; (3) a very low presurgical perfor-
mance, indicating a limited reserve; and (4) bilateral
pathology such as bilateral hippocampal sclerosis.106
These must be considered when selecting and advising
potential surgical patients about weighing the cognitive
risks against the chance of seizure freedom.
Psychiatric Antecedents and Sequelae of
Epilepsy Surgery
Three major questions arise concerning psychiatric dis-
turbances within the context of epilepsy surgery: (1)
Does a past or current psychiatric condition affect the
chances of seizure freedom? (2) Does epilepsy surgery
increase risk of de novo psychiatric disturbances or an
exacerbation of preexistent problems? and (3) Can epi-
lepsy surgery resolve psychiatric problems?
Interictal depression (5–50%), anxiety (0–48%),
interictal psychosis (0–16%), and suicidality are pressing
issues in pharmacoresistant epilepsy patients.107 Contrib-
utory causes include structural brain damage, active epi-
lepsy, and adverse side effects of antiseizure
medication.108 Furthermore, psychiatric comorbidity may
be reactive to the epilepsy and associated psychosocial
difficulties.
Past or current psychopathology is associated with a
lower chance of seizure freedom.109 This, however, is not
a contraindication for surgery,110 and successful surgery
may improve psychiatric symptoms, with improved
depression and anxiety after TLE surgery. A short-term
increase in psychiatric symptoms (especially anxiety) may
be followed by long-term improvement.107
The most significant risk factor for postsurgical psy-
chiatric problems is a presurgical affective disorder or a
lifetime psychiatric diagnosis.107
De novo psychopathology has been observed in 1
to 26% of patients after TLE surgery (depression, 4–
18%; anxiety, 3–26%; interictal psychosis, 1–12%107).
De novo psychiatric problems are associated with a pre-
operative history of secondary generalized tonic–clonic
seizures.107 The incidence of new psychogenic nonepilep-
tic seizures following epilepsy surgery is estimated at 4%,
being higher (8.5%) in females with a psychiatric
history.111,112
A systematic presurgical evaluation of psychopathol-
ogy and postoperative follow-up are appropriate, with
consideration of the causes of the psychopathology,
including organic, iatrogenic, and psychosocial aspects.
Therapeutic options can include antiseizure drugs with
positive psychotropic effects such as lamotrigine and
avoiding drugs with negative psychiatric risks.113 In addi-
tion, antidepressants or neuroleptics, and psychotherapy
can be used prior to and after surgery. Improvement of
psychiatric symptoms can be a positive by-product of
epilepsy surgery, and there are some striking cases of res-
olution of antisocial behavior.114
Social and Employment Consequences of
Epilepsy Surgery
Although the primary reason for patients undergoing epi-
lepsy surgery is seizure freedom, other aspects are also
taken into account, including anticipated psychosocial
and psychological improvements and a better quality of
life.
Major concerns for epilepsy patients include the
inability to drive, lack of independence, unemployment,
embarrassment, stigma, medication side effects, and inju-
ries.115 Patients expect improvements in these areas after
successful treatment.
An adverse outcome after surgery, 8% in one
study,116 would be unchanged or worsened seizure con-
trol accompanied by a decline in cognition. These
“double losers” report the most severe deteriorations in
HRQOL. In these patients, presurgical characteristics
indicate a lower chance of postsurgical seizure freedom
or a higher risk of cognitive decline,116 emphasizing the
need for careful patient selection, comprehensive presur-
gical diagnostics, and advising patients about the chances
and risks of surgery.
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Vocational Outcome
Data on vocational outcome after epilepsy surgery are
sparse, and studies report inconsistent findings, with
increased, unchanged, or decreased employment opportu-
nities after surgery.117 Postsurgical seizure freedom, a
younger age at surgery, and employment prior to surgery
increase the likelihood of a favorable vocational outcome.
A postsurgical rehabilitation program can improve
employment status.118 Furthermore, the prevalent job
market and social/welfare systems are potential
confounders.
Adjustment Issues—The Burden of Normality
Postsurgical seizure freedom can lead to adjustment
issues, the so-called “burden of normality.”119 Seizure
relief may decrease dependency and the level of consider-
ation displayed by others and increase expectations
toward the now “cured” patient. This may pose consider-
able pressure on the seizure-free patient, who is now
abruptly forced to cope with this new situation. Such a
constellation can overtax the patient, and cause depres-
sion and anxiety, and may destabilize a relationship that
was predicated on one party being dependent on the
other.
Expectation Management
The various outcome scenarios should be discussed with
patients prior to surgery. Psychosocial counseling is
important for evaluating individual risks/benefits as well
as the neuropsychological risks. Unrealistic expectations
must be managed and the inevitable uncertainty of indi-
vidual outcomes addressed. The prolonged nature of pre-
surgical evaluation enables counseling the patient and
their family on the possible sequelae of epilepsy surgery
and how to manage these. Epilepsy surgery strives for sei-
zure control, but it cannot guarantee a better life, even if
seizure freedom is achieved.
Evolving Practice of Epilepsy Surgery
As epilepsy surgery becomes more prevalent, it is frustrat-
ing that many patients wait years for referral to consider
this option. There have been changes in case mix in large
epilepsy surgery centers, with a reduction of the numbers
of patients with hippocampal sclerosis and an increase in
patients with complex epilepsies who require intracranial
EEG, and who do not have optimal characteristics. It is
crucial that epilepsy surgery centers are experienced and
multidisciplinary, and having made large investments in
the area, they must guard against the risk of overselling
epilepsy surgery and must recognize the limitation of
benefits and the potential adverse effects, and that some
individuals are not going to be improved by having part
of their brain removed.
Future challenges are first to ensure that all poten-
tial candidates for epilepsy surgery are evaluated in
appropriate centers after failing to gain seizure control
with 2 or 3 medications over 2 to 3 years. Second, non-
invasive diagnostic procedures must be improved, so that
those who will benefit from surgery are quickly selected
and others are directed to other treatment options.
Third, less invasive treatments must be devised, so that
craniotomies become rarities. Fourth, rehabilitation must
be improved, so that individuals and their families may
capitalize on the benefits accrued by surgery.
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